US FDA Allows Outsourcers To Compound Hydroxychloroquine As COVID-19 Drives Demand
Pharmacies Say More Additions Needed
The US FDA has added hydroxychloroquine sulfate to the list of drugs outsourcing facilities can compound as pharmacy group calls for more such approvals with COVID-19 driving demand for additional prescription and over-the-counter drugs.
